Floatz logo

Membrane-Bound Interleukin-21-Expanded Haploidentical Natural Killer Cells

Blasts 10 Percent or More of Bone Marrow Nucleated Cells

Sumithira VasuCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Blasts 10 Percent or More of Bone Marrow Nucleated Cells cohort.

Asset / SponsorPhaseRating
Fludarabine
Sumithira Vasu
Phase 2BB
Gilteritinib
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3BB
Cytosin-Arabinosid
Sumithira Vasu
Phase 2BB
Midostaurin
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3B
Thiotepa
Fred Hutchinson Cancer Center
Phase 2B

View all 29 →

Same molecule, other indications

Membrane-Bound Interleukin-21-Expanded Haploidentical Natural Killer Cells is also rated in:

acute myeloid leukemiaDormant
CCC
Indicative ·
50 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemiaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →